Piper Jaffray analyst Matt O'Brien views Straumann's acquisition of ClearCorrect and a 38% stake in Geniova as only a "modest incremental negative" for Align Technology. Align's 10 year head start should allow the company to remain the dominant clear aligner player for years to come, O'Brien tells investors in a research note. He recommends using the weakness in Align shares today as a buying opportunity. The analyst has a Overweight rating on the name.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here